Cargando…
Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
Biomarkers for disease diagnosis and prognosis are crucial in clinical practice. They should be objective and quantifiable and respond to specific therapeutic interventions. Optimal biomarkers should reflect the underlying process (pathological or not), be reproducible, widely available, and allow m...
Autores principales: | Monllor, Paloma, Cervera-Ferri, Ana, Lloret, Maria-Angeles, Esteve, Daniel, Lopez, Begoña, Leon, Jose-Luis, Lloret, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509134/ https://www.ncbi.nlm.nih.gov/pubmed/34639229 http://dx.doi.org/10.3390/ijms221910889 |
Ejemplares similares
-
The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
por: Lloret, Ana, et al.
Publicado: (2019) -
Obesity as a Risk Factor for Alzheimer’s Disease: Implication of Leptin and Glutamate
por: Lloret, Ana, et al.
Publicado: (2019) -
Is Oxidative Stress the Link Between Cerebral Small Vessel Disease, Sleep Disruption, and Oligodendrocyte Dysfunction in the Onset of Alzheimer’s Disease?
por: Lloret, Ana, et al.
Publicado: (2021) -
When Does Alzheimer′s Disease Really Start? The Role of Biomarkers
por: Lloret, Ana, et al.
Publicado: (2019) -
Is Sleep Disruption a Cause or Consequence of Alzheimer’s Disease? Reviewing Its Possible Role as a Biomarker
por: Lloret, Maria-Angeles, et al.
Publicado: (2020)